APO RESEARCH · REPORT
Critical Illness Insurance
Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.
Product & engineering
Understand the product.
Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.
The policy may also be structured to pay out regular income and the payout may also be on the policyholder undergoing a surgical procedure, for example, having a heart bypass operation.
Selected research
Industry Research
Critical Illness Insurance Industry Research Report 2026
Market perspective
Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.
The policy may also be structured to pay out regular income and the payout may also be on the policyholder undergoing a surgical procedure, for example, having a heart bypass operation.
Global critical illness insurance key players include China Life Insurance , Ping An Insurance, China Pacific Insurance, etc. Global top three manufacturers hold a share over 35%.
Read the full market overview
China is the largest market, with a share about 50%, followed by North America and Europe, both have a share about 30 percent.
In terms of application, the largest application is Cancer, followed by Heart Attack, Stroke, etc.
Report Scope
This report quantifies the global Critical Illness Insurance market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Critical Illness Insurance.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Critical Illness Insurance Market by Company
China Life Insurance
Ping An Insurance
China Pacific Insurance
Aviva
Legal & General
New China Life Insurance
AXA
Prudential plc
Aegon
Allianz
AIG
UnitedHealthcare
Zurich
MetLife
Dai-ichi Life Group
Sun Life Financial
Huaxia life Insurance
Aflac
Liberty Mutual
HCF
Generali Group
Royal London
Scottish Windows
Livepool Victoria
Vitality
Critical Illness Insurance Segment by Type
By Type
Fixed-term Insurance
Whole-life Insurance
By Age
<30 Years Old
30-40 Years Old
41-50 Years Old
>50 Years Old
Critical Illness Insurance Segment by Application
Cancer
Heart Attack
Stroke
Other
Critical Illness Insurance Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Critical Illness Insurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Critical Illness Insurance and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Critical Illness Insurance.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Critical Illness Insurance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fixed-term Insurance
- Whole-life Insurance
Applications
- Cancer
- Heart Attack
- Stroke
- Other
Companies covered
- China Life Insurance
- Ping An Insurance
- China Pacific Insurance
- Aviva
- Legal & General
- New China Life Insurance
- AXA
- Prudential plc
- Aegon
- Allianz
- AIG
- UnitedHealthcare
- Zurich
- MetLife
- Dai-ichi Life Group
- Sun Life Financial
- Huaxia life Insurance
- Aflac
- Liberty Mutual
- HCF
- Generali Group
- Royal London
- Scottish Windows
- Livepool Victoria
- Vitality
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Critical Illness Insurance By Type
- 2.2.1 Market Value Comparison By Type (2021 VS 2025 VS 2032)
- 2.2.2 Fixed-term Insurance
- 2.2.3 Whole-life Insurance
- 2.3 Critical Illness Insurance by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer
- 2.3.3 Heart Attack
- 2.3.4 Stroke
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Critical Illness Insurance Breakdown Data by Type
- 3.1 Global Critical Illness Insurance Historic Market Size by Type (2021-2026)
- 3.2 Global Critical Illness Insurance Forecasted Market Size by Type (2027-2032)
4 Critical Illness Insurance Breakdown Data by Application
- 4.1 Global Critical Illness Insurance Historic Market Size by Application (2021-2026)
- 4.2 Global Critical Illness Insurance Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Critical Illness Insurance Market Perspective (2021-2032)
- 5.2 Global Critical Illness Insurance Growth Trends by Region
- 5.2.1 Global Critical Illness Insurance Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Critical Illness Insurance Historic Market Size by Region (2021-2026)
- 5.2.3 Critical Illness Insurance Forecasted Market Size by Region (2027-2032)
- 5.3 Critical Illness Insurance Market Dynamics
- 5.3.1 Critical Illness Insurance Industry Trends
- 5.3.2 Critical Illness Insurance Market Drivers
- 5.3.3 Critical Illness Insurance Market Challenges
- 5.3.4 Critical Illness Insurance Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Critical Illness Insurance Players by Revenue
- 6.1.1 Global Top Critical Illness Insurance Players by Revenue (2021-2026)
- 6.1.2 Global Critical Illness Insurance Revenue Market Share by Players (2021-2026)
- 6.2 Global Critical Illness Insurance Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Critical Illness Insurance Head Office and Area Served
- 6.4 Global Critical Illness Insurance Players, Product Type & Application
- 6.5 Global Critical Illness Insurance Manufacturers Established Date
- 6.6 Global Critical Illness Insurance Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Critical Illness Insurance Market Size (2021-2032)
- 7.2 North America Critical Illness Insurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Critical Illness Insurance Market Size by Country (2021-2026)
- 7.4 North America Critical Illness Insurance Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Critical Illness Insurance Market Size (2021-2032)
- 8.2 Europe Critical Illness Insurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Critical Illness Insurance Market Size by Country (2021-2026)
- 8.4 Europe Critical Illness Insurance Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Critical Illness Insurance Market Size (2021-2032)
- 9.2 Asia-Pacific Critical Illness Insurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Critical Illness Insurance Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Critical Illness Insurance Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Critical Illness Insurance Market Size (2021-2032)
- 10.2 South America Critical Illness Insurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Critical Illness Insurance Market Size by Country (2021-2026)
- 10.4 South America Critical Illness Insurance Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Critical Illness Insurance Market Size (2021-2032)
- 11.2 Middle East & Africa Critical Illness Insurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Critical Illness Insurance Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Critical Illness Insurance Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 China Life Insurance
- 12.1.1 China Life Insurance Company Information
- 12.1.2 China Life Insurance Business Overview
- 12.1.3 China Life Insurance Revenue in Critical Illness Insurance Business (2021-2026)
- 12.1.4 China Life Insurance Critical Illness Insurance Product Portfolio
- 12.1.5 China Life Insurance Recent Developments
- 12.2 Ping An Insurance
- 12.2.1 Ping An Insurance Company Information
- 12.2.2 Ping An Insurance Business Overview
- 12.2.3 Ping An Insurance Revenue in Critical Illness Insurance Business (2021-2026)
- 12.2.4 Ping An Insurance Critical Illness Insurance Product Portfolio
- 12.2.5 Ping An Insurance Recent Developments
- 12.3 China Pacific Insurance
- 12.3.1 China Pacific Insurance Company Information
- 12.3.2 China Pacific Insurance Business Overview
- 12.3.3 China Pacific Insurance Revenue in Critical Illness Insurance Business (2021-2026)
- 12.3.4 China Pacific Insurance Critical Illness Insurance Product Portfolio
- 12.3.5 China Pacific Insurance Recent Developments
- 12.4 Aviva
- 12.4.1 Aviva Company Information
- 12.4.2 Aviva Business Overview
- 12.4.3 Aviva Revenue in Critical Illness Insurance Business (2021-2026)
- 12.4.4 Aviva Critical Illness Insurance Product Portfolio
- 12.4.5 Aviva Recent Developments
- 12.5 Legal & General
- 12.5.1 Legal & General Company Information
- 12.5.2 Legal & General Business Overview
- 12.5.3 Legal & General Revenue in Critical Illness Insurance Business (2021-2026)
- 12.5.4 Legal & General Critical Illness Insurance Product Portfolio
- 12.5.5 Legal & General Recent Developments
- 12.6 New China Life Insurance
- 12.6.1 New China Life Insurance Company Information
- 12.6.2 New China Life Insurance Business Overview
- 12.6.3 New China Life Insurance Revenue in Critical Illness Insurance Business (2021-2026)
- 12.6.4 New China Life Insurance Critical Illness Insurance Product Portfolio
- 12.6.5 New China Life Insurance Recent Developments
- 12.7 AXA
- 12.7.1 AXA Company Information
- 12.7.2 AXA Business Overview
- 12.7.3 AXA Revenue in Critical Illness Insurance Business (2021-2026)
- 12.7.4 AXA Critical Illness Insurance Product Portfolio
- 12.7.5 AXA Recent Developments
- 12.8 Prudential plc
- 12.8.1 Prudential plc Company Information
- 12.8.2 Prudential plc Business Overview
- 12.8.3 Prudential plc Revenue in Critical Illness Insurance Business (2021-2026)
- 12.8.4 Prudential plc Critical Illness Insurance Product Portfolio
- 12.8.5 Prudential plc Recent Developments
- 12.9 Aegon
- 12.9.1 Aegon Company Information
- 12.9.2 Aegon Business Overview
- 12.9.3 Aegon Revenue in Critical Illness Insurance Business (2021-2026)
- 12.9.4 Aegon Critical Illness Insurance Product Portfolio
- 12.9.5 Aegon Recent Developments
- 12.10 Allianz
- 12.10.1 Allianz Company Information
- 12.10.2 Allianz Business Overview
- 12.10.3 Allianz Revenue in Critical Illness Insurance Business (2021-2026)
- 12.10.4 Allianz Critical Illness Insurance Product Portfolio
- 12.10.5 Allianz Recent Developments
- 12.11 AIG
- 12.11.1 AIG Company Information
- 12.11.2 AIG Business Overview
- 12.11.3 AIG Revenue in Critical Illness Insurance Business (2021-2026)
- 12.11.4 AIG Critical Illness Insurance Product Portfolio
- 12.11.5 AIG Recent Developments
- 12.12 UnitedHealthcare
- 12.12.1 UnitedHealthcare Company Information
- 12.12.2 UnitedHealthcare Business Overview
- 12.12.3 UnitedHealthcare Revenue in Critical Illness Insurance Business (2021-2026)
- 12.12.4 UnitedHealthcare Critical Illness Insurance Product Portfolio
- 12.12.5 UnitedHealthcare Recent Developments
- 12.13 Zurich
- 12.13.1 Zurich Company Information
- 12.13.2 Zurich Business Overview
- 12.13.3 Zurich Revenue in Critical Illness Insurance Business (2021-2026)
- 12.13.4 Zurich Critical Illness Insurance Product Portfolio
- 12.13.5 Zurich Recent Developments
- 12.14 MetLife
- 12.14.1 MetLife Company Information
- 12.14.2 MetLife Business Overview
- 12.14.3 MetLife Revenue in Critical Illness Insurance Business (2021-2026)
- 12.14.4 MetLife Critical Illness Insurance Product Portfolio
- 12.14.5 MetLife Recent Developments
- 12.15 Dai-ichi Life Group
- 12.15.1 Dai-ichi Life Group Company Information
- 12.15.2 Dai-ichi Life Group Business Overview
- 12.15.3 Dai-ichi Life Group Revenue in Critical Illness Insurance Business (2021-2026)
- 12.15.4 Dai-ichi Life Group Critical Illness Insurance Product Portfolio
- 12.15.5 Dai-ichi Life Group Recent Developments
- 12.16 Sun Life Financial
- 12.16.1 Sun Life Financial Company Information
- 12.16.2 Sun Life Financial Business Overview
- 12.16.3 Sun Life Financial Revenue in Critical Illness Insurance Business (2021-2026)
- 12.16.4 Sun Life Financial Critical Illness Insurance Product Portfolio
- 12.16.5 Sun Life Financial Recent Developments
- 12.17 Huaxia life Insurance
- 12.17.1 Huaxia life Insurance Company Information
- 12.17.2 Huaxia life Insurance Business Overview
- 12.17.3 Huaxia life Insurance Revenue in Critical Illness Insurance Business (2021-2026)
- 12.17.4 Huaxia life Insurance Critical Illness Insurance Product Portfolio
- 12.17.5 Huaxia life Insurance Recent Developments
- 12.18 Aflac
- 12.18.1 Aflac Company Information
- 12.18.2 Aflac Business Overview
- 12.18.3 Aflac Revenue in Critical Illness Insurance Business (2021-2026)
- 12.18.4 Aflac Critical Illness Insurance Product Portfolio
- 12.18.5 Aflac Recent Developments
- 12.19 Liberty Mutual
- 12.19.1 Liberty Mutual Company Information
- 12.19.2 Liberty Mutual Business Overview
- 12.19.3 Liberty Mutual Revenue in Critical Illness Insurance Business (2021-2026)
- 12.19.4 Liberty Mutual Critical Illness Insurance Product Portfolio
- 12.19.5 Liberty Mutual Recent Developments
- 12.20 HCF
- 12.20.1 HCF Company Information
- 12.20.2 HCF Business Overview
- 12.20.3 HCF Revenue in Critical Illness Insurance Business (2021-2026)
- 12.20.4 HCF Critical Illness Insurance Product Portfolio
- 12.20.5 HCF Recent Developments
- 12.21 Generali Group
- 12.21.1 Generali Group Company Information
- 12.21.2 Generali Group Business Overview
- 12.21.3 Generali Group Revenue in Critical Illness Insurance Business (2021-2026)
- 12.21.4 Generali Group Critical Illness Insurance Product Portfolio
- 12.21.5 Generali Group Recent Developments
- 12.22 Royal London
- 12.22.1 Royal London Company Information
- 12.22.2 Royal London Business Overview
- 12.22.3 Royal London Revenue in Critical Illness Insurance Business (2021-2026)
- 12.22.4 Royal London Critical Illness Insurance Product Portfolio
- 12.22.5 Royal London Recent Developments
- 12.23 Scottish Windows
- 12.23.1 Scottish Windows Company Information
- 12.23.2 Scottish Windows Business Overview
- 12.23.3 Scottish Windows Revenue in Critical Illness Insurance Business (2021-2026)
- 12.23.4 Scottish Windows Critical Illness Insurance Product Portfolio
- 12.23.5 Scottish Windows Recent Developments
- 12.24 Livepool Victoria
- 12.24.1 Livepool Victoria Company Information
- 12.24.2 Livepool Victoria Business Overview
- 12.24.3 Livepool Victoria Revenue in Critical Illness Insurance Business (2021-2026)
- 12.24.4 Livepool Victoria Critical Illness Insurance Product Portfolio
- 12.24.5 Livepool Victoria Recent Developments
- 12.25 Vitality
- 12.25.1 Vitality Company Information
- 12.25.2 Vitality Business Overview
- 12.25.3 Vitality Revenue in Critical Illness Insurance Business (2021-2026)
- 12.25.4 Vitality Critical Illness Insurance Product Portfolio
- 12.25.5 Vitality Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst